Ketamine (0.25 mg/kg)

DRUG2 trials

Sponsors

Soterix Medical, Mayo Hospital Lahore

Conditions

Postoperative ShiveringPostspinal ShiveringTreatment Resistant Depression (TRD)

Phase 1

Ketamine Biomarker Validation

Not yet recruitingNCT07307768

Soterix MedicalTreatment Resistant Depression (TRD)

Start: 2025-12-20End: 2028-03-01Target: 20Updated: 2025-12-29

Unknown Phase

Comparison of Intravenous Ondansetron and Low Dose Ketamine in Preventing Post Spinal Shivering

CompletedNCT07334223

Mayo Hospital LahorePostoperative Shivering, Postspinal Shivering

Start: 2020-01-01End: 2020-06-30Updated: 2026-01-12